《大行報告》匯豐研究上調美團(03690.HK)目標價至250元 評級「買入」
匯豐研究發表研報指,美團(03690.HK)第二季業績勝預期,收入較預測高5%,EBITDA轉正達到38億元人民幣,對比市場預期錄得輕微虧損。
雖然面對疫情及宏觀不確定性,但考慮到近期市場數量,該行外賣以及店內、酒店和旅遊業務收入恢復速度可能會出人意料,因此將美團2022至2024年的收入預測上調3%至4%。
該行又指,美團EBITDA轉正增強了對其盈利潛力的信心,但計及成本可能會上升,因此將2022至2024年的淨利潤預測上調3%至27%,預期來自抖音的新競爭不太可能成爲主要威脅,維持「買入」評級,目標價由240元上調至250元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.